A Robust Workflow for Biosimilar Comparability Assessment via Intact and Subunit RPLC-MS and Native IEX-MS with the Xevo G3 QTof MS Platform
Applications | 2022 | WatersInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma
ManufacturerWaters
Key wordsremicade, renflexis, intact, subunit, iex, rplc, innovator, comparability, biosimilar, variant, spectra, bioresolvetm, samantha, owen, unifitm, avsola, emma, xevotm, inflectra, lisa, qing, raw, ying, carboxypeptidase, scott, via, ides, glycoform, analyses, infliximab, scx, prove, unifi, establishing, were, agencies, attribute, terminal, lysine, consistently, streamlined, triplicate, deconvoluted, offered, qtof, digested, assays, native, digest, mab
Similar PDF
A Robust Workflow for Biosimilar Comparability Assessment via Intact and Subunit RPLC-MS and Native IEX-MS with a Prototype Benchtop QTOF
2022|Waters|Posters
MP012 A Robust Workflow for Biosimilar Comparability Assessment via Intact and Subunit RPLC-MS and Native IEX-MS with a Prototype Benchtop QTOF Charge Variant Analysis (IEX-MS) Samantha Ippoliti1; Owen Cornwell2; Lisa Reid2; Ying Qing Yu1; Emma Harry2; Scott Berger1; 1Waters Corporation,…
Key words
remicade, remicaderenflexis, renflexisiex, iexintact, intactsubunit, subunitrplc, rplcinnovator, innovatorcomparability, comparabilitybiosimilar, biosimilarvariant, variantqtof, qtofspectra, spectrabioresolvetm, bioresolvetmavsola, avsolaunifitm
Comprehensive Biosimilar Comparability Assessment via Intact and Subunit RP-MS and IEX-UV-MS Using the Xevo™ G3 QTof System
2022|Waters|Applications
Application Note Comprehensive Biosimilar Comparability Assessment via Intact and Subunit RP-MS and IEX-UV-MS Using the Xevo™ G3 QTof System Samantha Ippoliti, Owen Cornwell, Lisa Reid, Ying Qing Yu, Emma Harry, Mark Towers Waters Corporation Abstract With the increasing prevalence of…
Key words
subunit, subunitcomparability, comparabilitybiosimilar, biosimilariex, iexintact, intactassessment, assessmentvia, viacomprehensive, comprehensiveusing, usingcarboxypeptidase, carboxypeptidasemab, mabterminal, terminallysine, lysinevariant, variantvariants
Applying Peptide Mapping and Multi- Attribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform
2022|Waters|Applications
Application Note Applying Peptide Mapping and MultiAttribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform Kellen DeLaney, Samantha Ippoliti, Lisa Reid, Owen Cornwell, Ying Qing Yu, Emma Harry, Mark Towers Waters Corporation Abstract…
Key words
biosimilar, biosimilarmam, mamattribute, attributemapping, mappingpeptide, peptidemab, mabapplying, applyingdrug, drugworkflow, workflowmulti, multiproducts, productsmethod, methodattributes, attributesinnovator, innovatorthorough
Multi-Attribute Methods for Biopharmaceutical Analysis
2022|Waters|Guides
[ APPLICATION NOTEBOOK ] Multi-Attribute Methods for Biopharmaceutical Analysis Application Notes [ APPLICATION NOTEBOOK ] Introduction The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years. The ability…
Key words
notebook, notebookattribute, attributebiopharmaceutical, biopharmaceuticalreturn, returnmulti, multimam, mamapplication, applicationcontents, contentspeptide, peptideattributes, attributesmethods, methodsacquity, acquitymab, mabbioaccord, bioaccordmonitoring